VAXXVaxxinity Inc. Class A Common Stock
0.0001USD0.00%Mkt Cap: 12678 $P/E: —4d ago
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap12.68K $
Enterprise Value-15.46M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-56.93M $
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterDec 2023
Employees57
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.28
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-0.05
EPS (Forward)-0.38
52W Range
0.00010% of range0.2000
52W High0.2000 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-424.60%
ROA-128.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-57.24M $
CapEx (TTM)803.00K $
FCF Margin—
FCF Yield-294818.77%
Net Debt-15.47M $
Net Debt/EBITDA0.28
Balance Sheet
Debt/Equity1.13
Current Ratio1.89
Quick Ratio1.76
Book Value/Sh0.1060 USD
Cash/Share0.2420 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.112.91M
Float112.87M
Insiders0.00%
Institutions0.02%
Short Interest
Short Ratio14.0d
Short % Float108.73%
Short % Out.3.33%
Shares Short4.22M
Short (prev mo.)3.85M
Technical
SMA 500.0048 (-97.9%)
SMA 2000.0037 (-97.3%)
Beta-74.44
S&P 52W Chg18.16%
Avg Vol (30d)2.08K
Avg Vol (10d)23.10K
Technical Indicators
RSI (14)47.4
MACD0.0003
MACD Signal-0.0004
MACD Hist.+0.0007
BB Upper0.0127 USD
BB Middle0.0014 USD
BB Lower-0.0100 USD
BB Width1633.11%
ATR (14)0.0109 USD
Vol Ratio (20d)15.17x